[Neurosurgical aspects of the treatment of neuroblastoma patients].
Neuroblastoma (NB) is the most common extracranial solid tumor in children. The neoplasm grows from progenitor cells of the sympathetic nervous system and can be detected anywhere along the sympathetic neurological circuit: retroperitoneally, mediastinally, cervically, and pelvically. Examination of children with suspected neuroblastoma is comprehensive and performed in strict compliance with a therapeutic protocol. A decision on the treatment regimen is made based on the tumor staging and the risk group of the patient. The diagnosis and treatment of NB patients are comprehensive and can be fully carried out only at the pediatric oncology department. In 10-15% of cases, an hourglass tumor spreads to the intervertebral foramina or spinal canal at one or more levels. A tumor node is always located extradurally with respect to the spinal cord. Symptoms of spinal cord compression of various severity are observed in 5-7% of patients. We present several cases of patients with neuroblastoma with intraspinal extension. Despite apparent benefits of primary surgical decompression of the spinal cord, modern experience of treatment of children with intraspinal tumor extension does not reveal advantages of surgery over chemotherapy. Neurological disorders of various nature and severity persist in the majority of patients in the long-term period, regardless of primary treatment. A higher level of spinal deformities after surgical tumor resection is observed. The issue of spinal cord decompression should be discussed by the neurosurgeon and pediatric oncologist, and the most common method of choice may be chemotherapy. The article discusses the indications and contraindications for neurosurgical interventions in NB patients and addresses the issues of NB metastasis to the brain and cranial bones as well as the opsoclonus-myoclonus syndrome.
Dmitry Rogachev Federal Scientific of Hematology, Oncology and Immunology, Moscow, Russia.
S S
SS
Ozerov
Dmitry Rogachev Federal Scientific of Hematology, Oncology and Immunology, Moscow, Russia.
A E
AE
Samarin
Dmitry Rogachev Federal Scientific of Hematology, Oncology and Immunology, Moscow, Russia.
E S
ES
Andreev
Dmitry Rogachev Federal Scientific of Hematology, Oncology and Immunology, Moscow, Russia.
G V
GV
Tereshchenko
Dmitry Rogachev Federal Scientific of Hematology, Oncology and Immunology, Moscow, Russia.
D Yu
DY
Kachanov
Dmitry Rogachev Federal Scientific of Hematology, Oncology and Immunology, Moscow, Russia.
T V
TV
Shamanskaya
Dmitry Rogachev Federal Scientific of Hematology, Oncology and Immunology, Moscow, Russia.
S R
SR
Varfolomeeva
D019299:Decompression, Surgical / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009447:Neuroblastoma / Q000000981:diagnostic imaging / Q000601:surgery*; D019635:Neurosurgical Procedures / Q000009:adverse effects*; D010524:Peripheral Nervous System Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*; D011183:Postoperative Complications; D013120:Spinal Cord Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*